Primary Record
Sirolimus
- In stock
- 8,946 g
- Purity
- 99.8 %
- CAS
- 53123-88-9
Compound Identifiers & Properties
- CAS
- 53123-88-9
- PubChem CID
- 21944094
- SMILES
- C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C\[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC
- Canonical SMILES
- CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C\C=C\C=C\1C
Names & Synonyms
- Sirolimus
- rapamycin
- Rapamune
- Rapammune
- sirolimusum
- Supralimus
- Perceiva
- Cypher
- (-)-Rapamycin
- RAPA
- Rapamycin (TN)
- Rapamycin (GMP)
- Rapamycin/Sirolimus
- LCP-Siro
- Rapamune (TN)
- Rapamycin (Sirolimus)
- 53123-88-9
- Sirolimus (Rapamycin)
- Antibiotic AY 22989
- Sirolimus (RAPAMUNE)
- RAPAMYCIN 25MG
- Sirolimus (USAN/INN)
- Everolimus EP Impurity A
- RefChem:1097959
- mTOR Inhibitor, Rapamycin
- Sirolimus [USAN:BAN:INN]
- D03LJR
- D0Q5YP
- Rapamycin C-7, analog 4
- SILA 9268A
- Sirolimus (MTOR inhibitor)
- C51H79NO13
- Rapamycin Immunosuppressant Drug
- UNII-W36ZG6FT64
- Sirolimus [USAN:INN:BAN]
- Sirolimus, Rapamune,Rapamycin
- CCRIS 9024
- Rapamycin =98% (by HPLC)
- SIIA 9268A
- DTXSID5023582
- BDBM92863
- ERK5-3O13
- HSDB 7284
- MS-R001
- AY 22989
- MSK10252
- Rapamycin, 98% - 25MG 25mg
- Wy 090217
- BBF-02627
- DE-109
- I2190A
- MFCD00867594
- AY-22989
- C51-H79-N-O13
- CID5284616
- I 2190A
- I-2190A
- NSC 226080
- WY-090217
- Rapamycin from Streptomyces hygroscopicus
- CID:21944094
- SID:53787256
- AY 22 989
- AY 22-989
- FT-0776766
- EC 610-965-5
- SIROLIMUS (RAPAMYCIN) (REFERENCE GRADE)
- sirolimus; 53123-88-9; C51H79NO13
- A851345
- D020123
- 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
- 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
- heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
- 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-C)(1,4)-oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
- RAP
- RPM